Multivariable Prediction Model for Biochemical Response to First-Generation Somatostatin Receptor Ligands in Acromegaly

Decreasing mortality and changes in treatment patterns in patients with acromegaly from a nationwide study

(2018) Daniela Esposito et al.   EUROPEAN JOURNAL OF ENDOCRINOLOGY

A Consensus Statement on acromegaly therapeutic outcomes

(2018) Shlomo Melmed et al.   Nature Reviews Endocrinology

The causes and consequences of pituitary gigantism

(2018) Albert Beckers et al.   Nature Reviews Endocrinology

Acromegaly at diagnosis in 3173 patients from the Liège Acromegaly Survey (LAS) Database

(2017) Patrick Petrossians et al.   ENDOCRINE-RELATED CANCER

A multivariable prediction model for pegvisomant dosing: monotherapy and in combination with long-acting somatostatin analogues

(2017) S E Franck et al.   EUROPEAN JOURNAL OF ENDOCRINOLOGY

Association between dopamine and somatostatin receptor expression and pharmacological response to somatostatin analogues in acromegaly

(2017) Eva Venegas-Moreno et al.   JOURNAL OF CELLULAR AND MOLECULAR MEDICINE

T2-weighted MRI signal predicts hormone and tumor responses to somatostatin analogs in acromegaly

(2016) Iulia Potorac et al.   ENDOCRINE-RELATED CANCER

Interpreting biochemical control response rates with first-generation somatostatin analogues in acromegaly

(2015) Annamaria Colao et al.   Pituitary

Acromegaly: An Endocrine Society Clinical Practice Guideline

(2014) Laurence Katznelson et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Pasireotide Versus Octreotide in Acromegaly: A Head-to-Head Superiority Study

(2014) A. Colao et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Somatostatin receptor ligands and resistance to treatment in pituitary adenomas

(2014) Daniel Cuevas-Ramos et al.   JOURNAL OF MOLECULAR ENDOCRINOLOGY

Tumor Shrinkage With Lanreotide Autogel 120 mg as Primary Therapy in Acromegaly: Results of a Prospective Multicenter Clinical Trial

(2013) Philippe J. Caron et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

The Liege Acromegaly Survey (LAS): A new software tool for the study of acromegaly

(2012) Patrick Petrossians et al.   ANNALES D ENDOCRINOLOGIE

The Metabolic Profile in Active Acromegaly is Gender-Specific

(2012) A. Ciresi et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Immunoreactivity Score Using an Anti-sst2A Receptor Monoclonal Antibody Strongly Predicts the Biochemical Response to Adjuvant Treatment with Somatostatin Analogs in Acromegaly

(2012) Federico Gatto et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Meta-Analysis on the Effects of Octreotide on Tumor Mass in Acromegaly

(2012) Andrea Giustina et al.   PLoS One

Novel pathway for somatostatin analogs in patients with acromegaly

(2012) Mônica R. Gadelha et al.   TRENDS IN ENDOCRINOLOGY AND METABOLISM

Resistance to Somatostatin Analogs in Acromegaly

(2011) Annamaria Colao et al.   ENDOCRINE REVIEWS

Diabetes in acromegaly, prevalence, risk factors, and evolution: data from the French Acromegaly Registry

(2011) Sandrine Fieffe et al.   EUROPEAN JOURNAL OF ENDOCRINOLOGY

Clinical Characteristics and Therapeutic Responses in Patients with Germ-LineAIPMutations and Pituitary Adenomas: An International Collaborative Study

(2010) Adrian F. Daly et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Medical Therapy in Patients with Acromegaly: Predictors of Response and Comparison of Efficacy of Dopamine Agonists and Somatostatin Analogues

(2009) M. Sherlock et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Acromegaly pathogenesis and treatment

(2009) Shlomo Melmed   JOURNAL OF CLINICAL INVESTIGATION

Effects of lanreotide SR and Autogel on tumor mass in patients with acromegaly: a systematic review

(2009) Gherardo Mazziotti et al.   Pituitary

Rapid and sustained reduction of serum growth hormone and insulin-like growth factor-1 in patients with acromegaly receiving lanreotide Autogel® therapy: a randomized, placebo-controlled, multicenter study with a 52 week open extension

(2009) Shlomo Melmed et al.   Pituitary

Quantitative analysis of somatostatin receptor subtypes (1–5) gene expression levels in somatotropinomas and correlation to in vivo hormonal and tumor volume responses to treatment with octreotide LAR

(2008) Giselle F Taboada et al.   EUROPEAN JOURNAL OF ENDOCRINOLOGY

A Critical Analysis of Clinically Available Somatostatin Analog Formulations for Therapy of Acromegaly

(2008) Robert D. Murray et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Mortality in Acromegaly: A Metaanalysis

(2007) O. M. Dekkers et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM